Literature DB >> 35898243

Leukocytoclastic Vasculitis Following COVID-19 Vaccination: A Case Report.

Juny Sebastian1, Merrin Mathew1, Veeranna Sharsty1, Madhan Ramesh1.   

Abstract

Background: Hypersensitivity or Leukocytoclastic vasculitis (LCV) following the COVID-19 vaccination has been reported rarely all over the world. LCV can be induced by certain factors such as infections, autoimmune disorders, malignancy, or some classes of drugs. Case presentation: A 32-year-old man, who was a known case of seizure disorder from his childhood presented to the department of dermatology with itchy red lesions on extremities and abdomen for the past 1 month. He explains a history of COVID-19 vaccination 1-month back and experienced itching on his lower limbs on the same day at night. A gradual worsening of the condition was observed day by day. He was hospitalized and diagnosed as LCV through clinical and laboratory findings.
Conclusion: This case highlights a temporal association with the event of vaccination. The causality assessment showed an indeterminate causal association to LCV with COVID-19 Vaccination.
© The Author(s) 2021.

Entities:  

Keywords:  adverse drug reactions; adverse drug reactions reporting/monitoring; skin; vaccines

Year:  2021        PMID: 35898243      PMCID: PMC9310316          DOI: 10.1177/00185787211067379

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  7 in total

1.  Incidence of leukocytoclastic vasculitis, 1996 to 2010: a population-based study in Olmsted County, Minnesota.

Authors:  Amrita Arora; David A Wetter; Tania M Gonzalez-Santiago; Mark D P Davis; Christine M Lohse
Journal:  Mayo Clin Proc       Date:  2014-06-27       Impact factor: 7.616

Review 2.  Vasculitis as an adverse event following immunization - Systematic literature review.

Authors:  Caterina Bonetto; Francesco Trotta; Patrizia Felicetti; Graciela S Alarcón; Carmela Santuccio; Novilia Sjafri Bachtiar; Yolanda Brauchli Pernus; Rebecca Chandler; Giampiero Girolomoni; Robert D M Hadden; Merita Kucuku; Seza Ozen; Barbara Pahud; Karina Top; Frederick Varricchio; Robert P Wise; Giovanna Zanoni; Saša Živković; Jan Bonhoeffer
Journal:  Vaccine       Date:  2015-09-21       Impact factor: 3.641

Review 3.  Hypersensitivity and vaccines: an update.

Authors:  Annick Barbaud; Antoine Deschildre; Julie Waton; Nadia Raison-Peyron; Philippe Tréchot
Journal:  Eur J Dermatol       Date:  2013-04-01       Impact factor: 3.328

Review 4.  Systemic vasculitis.

Authors:  Poonam Sharma; Sanjeev Sharma; Richard Baltaro; John Hurley
Journal:  Am Fam Physician       Date:  2011-03-01       Impact factor: 3.292

Review 5.  Diagnosis and management of leukocytoclastic vasculitis.

Authors:  Paolo Fraticelli; Devis Benfaremo; Armando Gabrielli
Journal:  Intern Emerg Med       Date:  2021-03-13       Impact factor: 3.397

6.  Planning for COVID-19 vaccines safety surveillance.

Authors:  Sonali Kochhar; Daniel A Salmon
Journal:  Vaccine       Date:  2020-07-10       Impact factor: 3.641

Review 7.  COVID-19 Vaccine Frontrunners and Their Nanotechnology Design.

Authors:  Young Hun Chung; Veronique Beiss; Steven N Fiering; Nicole F Steinmetz
Journal:  ACS Nano       Date:  2020-10-09       Impact factor: 15.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.